Product Information

POTASSIUM CITRATE ER 10 MEQ TB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1798 per EA under NDC 16571086501. Its NADAC has been published 63 times since Jun 11, 2025.

FDA first approved this application on Jun 9, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 10 MEQ TB

potassium citrate
$0.1798per EA

Strength

1080 mg/1

NDC

16571086501

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077440

FDA Approved

6/9/2006

TE Code

AB

On Market Since

12/15/2024

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 10 MEQ TB has been published 63 times since Jun 11, 2025, and over the history we have for it it has declined 18.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1798 per EA
All-time high$0.2205 (Jun 11, 2025)
All-time low$0.1666 (Sep 17, 2025)
52-week high$0.1831
52-week low$0.1666
Median price$0.1785
Average price$0.1811
Largest weekly change-10.5% (Jul 23, 2025)
Weeks tracked63
Tracking sinceJun 11, 2025

Price History

1W

-0.8%

1M

-0.8%

3M

+0.8%

6M

+3.9%

1Y

-1.8%

3Y

N/A

5Y

N/A

All

-18.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the potassium citrate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 10 MEQ TB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 10 MEQ TB, manufactured by Rising Pharma Holdings Inc., is $0.1798 per EA (NDC 16571086501), effective Aug 19, 2026.

How has the price of POTASSIUM CITRATE ER 10 MEQ TB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has declined 18.5%. It has been tracked across 63 weekly CMS publications since Jun 11, 2025.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 10 MEQ TB?

Since Jun 11, 2025, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has ranged from a low of $0.1666 (Sep 17, 2025) to a high of $0.2205 (Jun 11, 2025), with a median of $0.1785 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 10 MEQ TB?

No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CITRATE ER 10 MEQ TB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures POTASSIUM CITRATE ER 10 MEQ TB?

POTASSIUM CITRATE ER 10 MEQ TB (NDC 16571086501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.